Navigation Links
Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds
Date:7/6/2011

BPH, such as alpha-blockers, have little effect on nocturia and given the significant limitations of other therapies, there are few options available to patients.

VA111913 - Dysmenorrhoea

VA111913 is a small molecule oral drug candidate, discovered by Vantia Therapeutics, and in clinical development for the treatment of dysmenorrhoea, a condition characterised by abnormal contractions of the uterus during menstruation causing severe, and often debilitating pain.

VA111913 acts by blocking vasopressin V1a receptors in the uterus wall to reduce abnormal contraction, thereby offering the potential to be the first drug that directly targets the cause of the pain associated with dysmenorrhoea.

There are currently no targeted therapies for dysmenorrhoea and treatments in common use include over-the-counter painkillers or oral contraceptives used 'off-label'. The market opportunity for a targeted drug for the management of dysmenorrhoea is estimated to be in excess of US$1 billion per year.

Contact details:
Vantia Therapeutics
Andrew Crockett, CEO : +44(0)238-076-3456 /+44(0)787-255-9676
info@vantia.com

Citigate Dewe Rogerson
Chris Gardner / Mark Swallow / Nina Enegren : +44(0)207-638-9571
vantia@citigatedr.co.uk



'/>"/>
SOURCE Vantia Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vantia Therapeutics Pipeline Continues to Mature
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Vantia Therapeutics Lead Candidate VA106483 Enters Phase IIb Trial for Nocturia
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... Inc., a leading full-service provider of dental consumables, implants ... into Japan , the world,s 2 ... the number of countries in which the Company operates. ...
(Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... LLC today announced the appointment of Erica L. Mann as ... business based in Morristown, NJ, USA, with operations in more ... million.  Ms. Mann also becomes a member of the Bayer ... 14, 2011. Ms. Mann most recently served as ...
... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: North American ... This research covers the state ... and restraints for growth, key trends, and end-user ...
Cached Medicine Technology:Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 2Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 3
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, ... and announced that JustHost, GoDaddy and HostMonster are ... market. VPS (Virtual Private Server) is the method ... servers, each of which has the appearance and ... That is why the site pays close attention ...
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses and ... evening dresses . All the company’s old and ... discount is up to 66 percent off. , ... fashion field. Its dress specialists are striving to make ... of the world. All the company’s items are unique, ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
(Date:10/19/2014)... spondylitis is a systemic disease that causes inflammation ... have affected members of the ancient Egyptian royal ... Arthritis & Rheumatology , a journal of the ... finding instead a degenerative spinal condition called diffuse ... from the 18th to early 20th Dynasties. ...
(Date:10/19/2014)... 2014 The federal litigation involving ... move forward in Massachusetts federal court, where more ... the dialysis medication, Bernstein Liebhard LLP reports. ... shows 2,127 claims now filed over GranuFlo and ... U.S. District Court, District of Massachusetts. Plaintiffs in ...
Breaking Medicine News(10 mins):Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 3Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 4
... Cediranib reduces tissue swelling better than steroids, ... -- Anti-angiogenesis drugs reduce edema (swelling of brain ... a new study suggests. , Anti-angiogenesis drugs prevent ... need to grow, the researchers pointed out. , ...
... , Big Boi, Asher Roth, Keri Hilson, Perez ... National Campaign with the Kaiser Family Foundation, Planned Parenthood and Others ... Outreach One in Two Sexually-Active Americans Contracts ... April 2 MTV and the ...
... through a long period of relative dormancy after a series of ... the U.S. Food and Drug Administration approved them for use in ... Zeff, MD comments on why he feels the FDA’s decision was ... ...
... Stylist, Lauri Eisenberg, Offers Her No-Sweat Fashion Tips ,So Excessive Perspiration ... ... April 2, 2009 -- If you,d never consider wearing silk or ... marks, you pick patterns over solids to hide the issue, or ...
... DUSSELDORF, Germany, April 2 In the first,quarter of ... total sales figure of EUR237.3m (Q1 2008: EUR239.1m) almost ... in the world economy. In,the core business, however, sales ... EUR228.7m , The operating result ...
... to deploy HealtheTrax(TM) for Sleep Services of AmericaELKRIDGE, ... thought leader in health information technologies, today announced ... its HealtheTrax(TM) software service with Sleep Services of ... CPAP therapy in Maryland. HealtheTrax(TM) is the ...
Cached Medicine News:Health News:Drug Improves Survival in Mice With Brain Tumors 2Health News:MTV Unwraps GYT: Get Yourself Tested 2Health News:MTV Unwraps GYT: Get Yourself Tested 3Health News:MTV Unwraps GYT: Get Yourself Tested 4Health News:MTV Unwraps GYT: Get Yourself Tested 5Health News:MTV Unwraps GYT: Get Yourself Tested 6Health News:MTV Unwraps GYT: Get Yourself Tested 7Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 2Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 3Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 4Health News:Don't Sacrifice Style Because of Sweat 2Health News:Don't Sacrifice Style Because of Sweat 3Health News:Don't Sacrifice Style Because of Sweat 4Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 2Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 3Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 4Health News:New Virtual Health Assistant Introduced 2Health News:New Virtual Health Assistant Introduced 3
Bipolar forceps...
... in vitro Nucleic Acid Hybridization ... Microplate Chemiluminescence for the Qualitative ... Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and ... High-Risk Groups in Cervical Specimens: ...
... radiation protection-0.62mm (+/- .05)Pb lead glass equivelant ... their level of protection, they are incredibly ... on your bridge while hugging your face ... corrective lenses, you can order Leaded Eyeglasses ...
... time in the world, there is a now ... diagnose VVC in female patients. CanDia5® is a ... the Candida antigens almost instantaneously (within 5 minutes) ... There is no similar POC product for VVC ...
Medicine Products: